Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2799)	6/15/2010 11:21:06 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

MIPI has already closed its Apr21 UG.<g> It was up 82.44% and is still up 64.12% on volume about 2x its ADV The stock opened without an UG and it seems that it wants to test the resistance at the $2.50 level.<g> bigcharts.marketwatch.com MIPI presented data demonstrating the utility of its radiopharmaceutical compounds for the molecular imaging of prostate and other tumors at the Society of Nuclear Medicine annual meeting. It also announced the receipt of SNM's 2010 Berson-Yalow Award for a nonclinical study demonstrating the potential of MIPI's compound 99mTc-MIP-1340 to provide accurate imaging of metastatic prostatic Ca. The ACTAY is $2.50 MIPI had a larger loss on the 1stQ in spite of 181% better revenues.<g> But the L for the current Yr, is expected around $1.75 vs. $2.64 in 2009. For 2011 a further trim of to the L to around $1.20 is expected. It seems that with some good news the stock can test again the $4 level.<g> bigcharts.marketwatch.com Bernard